Sun Pharmaceutical Industries Ltd.
Search Company
Registered Address
Registered Office : Sun Pharma Advanced Research Centre (SPARC), Tandalja,
Vadodra, Gujarat - 390012
Tel: 0265-6615500, 6615600, 6615700
Fax: 0265-2354897
Email : secretarial@sunpharma.com
Website : http://www.sunpharma.com
Key Officials
Name Designation
Mr. C S Muralidharan Chief Financial Officer
Mr. Abhay Gandhi CEO - North America
Dr. Uday Baldota CEO - Taro Pharmaceutical Industries Ltd.
Listings
BSE , BSE , MCXSX , NSE , NSE ,  
Standalone Consolidated
You are viewing standalone data.
Quarterly Results
Dec 23 Sep 23 Jun 23
Sales 5,073.75 5,096.21 4,466.07
Other Income 76.80 106.54 163.54
Total Expenses 3,487.55 3,445.24 3,304.25
Operating Profit 1,586.20 1,650.97 1,161.82
Interest 214.92 193.63 157.94
Gross Profit 1,220.88 1,299.23 954.36
Provisions Made 0.00 0.00 0.00
Depreciation 399.60 392.71 415.27
Taxation 30.16 17.89 9.24
Net Profit / Loss 721.31 888.63 380.64
Equity Capital 239.93 239.93 239.93
Balance Sheet
Mar 23 Mar 22 Mar 21
Share Capital 239.93 239.93 239.93
Reserve & Surplus 23,508.43 24,348.02 24,800.23
Revaluation Reserve 0.00 0.00 0.00
Networth 23,748.36 24,587.95 25,040.16
Total debt 7,592.67 4,868.71 6,485.54
Total Liability 31,341.03 29,456.66 31,525.70
Net Block 8,711.67 9,712.78 5,244.36
Capital work in progress 852.91 828.64 762.79
Investment 12,616.40 15,548.87 16,998.68
Net current asset 9,160.05 3,366.37 8,519.87
Miscellaneous expenses 0.00 0.00 0.00
Total Assets 31,341.03 29,456.66 31,525.70
Income Statement
  Mar23 Mar22 Mar21
Sales 20,812.14 15,585.98 12,803.21
Other Income 279.03 957.92 150.22
Total Expenses 14,339.28 12,678.46 9,867.21
Operating Profit 6,472.86 2,907.52 2,936.00
Interest 472.18 388.10 256.98
Adjusted PBDIT 6,751.89 3,865.44 3,086.22
Depreciation 1,600.87 1,349.95 586.81
Adjusted PBT 4,678.84 2,127.39 2,242.43
Taxation 50.33 406.85 13.17
Net Profit / Loss 1,690.72 -99.99 2,139.70
Key Ratios
  Mar23 Mar22 Mar21
OPM (%) 31.10 18.65 22.93
GPM (%) 23.40 9.99 18.34
NPM (%) 8.12 -0.64 16.71
Earning Retention Ratio 45.57 -25.47 30.07
Return on networth (%) 7.11 -0.40 8.54
EPS (Rs.) 7.05 -0.41 8.92
Dividend payout Ratio 149.00 0.00 72.86
Longterm Debt-Equity Ratio 0.31 0.19 0.19
Current Ratio 1.95 1.30 2.14
Fixed Asset Turnover Ratio 0.68 0.51 0.41
Inventory 0.66 0.52 0.40
Interest coverage Ratio 14.30 9.96 12.01
Registrar Details
Link Intime India Pvt. Ltd.
C 101, 247 Park, L.B.S. Marg, Vikhroli (West)
Mumbai,400083,Maharashtra
Tel : 022-49186270
Fax : 49186060
BSE
Market Performance
Exchange BSE
Last Traded Price (Rs.) 1,504.25
Last Traded Date 26/04/2024
Last Traded Time -
Change (%) -1.07%
Day's Open (Rs.) 1,529.90
Previous Close (Rs.) 1,520.55
Day's High (Rs.) 1,530.05
Day's Low (Rs.) 1,499.65
Volume (Rs. In Lacs) 2099.10
Bid Price (Rs.) 0.00
Bid Quantity
Offer Price (Rs.) 0.00
Offer Quantity
Exchange Code 524715
Exchange Group A
Board Meetings
Date Purpose
31/01/2024 Quarterly Results & Interim Dividend
01/11/2023 Quarterly Results
03/08/2023 Quarterly Results
Corporate News
Sun Pharma. - Disclosure under SEBI Takeover Regulations
Sun Pharma. - Compliance Certificate Under Regulation 40(9) & (10) Of SEBI (Listing Obligations And Disclosure Requirements)
Sun Pharma. - Loss/Duplicate-Share Certificate-XBRL
Sun Pharma. - Loss of Share Certificates
Sun Pharma. - Updates
Share Holding Pattern as on 31/03/2024
Major Holder No. of Shares Percentage(%)
Promoters 1,307,134,535 54.48
Institutional Investors 876,908,769 36.55
Other Investors 84,788,162 3.53
General Public 130,503,504 5.44